Business Context and Reporting Period
Company: Genprex, Inc. (GNPX)
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2026
Reporting Period: Event date January 7, 2026; Signed January 9, 2026
Context: The filing addresses the Company's status regarding Nasdaq listing requirements, specifically the Minimum Stockholders' Equity Rule.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the regulatory threshold for compliance:
- Minimum Stockholders' Equity Requirement: $2.5 million (Nasdaq Listing Rule 5550(b)(1)).
- Compliance Status: The Company has regained compliance with the $2.5 million equity requirement.
Material Changes
Regulatory Status Change:
- Previous Status: On August 19, 2025, Nasdaq notified the Company of non-compliance with the Minimum Stockholders' Equity Rule.
- Current Status: On January 7, 2026, the Nasdaq Hearings Panel determined the Company has regained compliance.
- Monitoring Period: The Company is subject to a mandatory panel monitor through January 7, 2027.
Outlook, Risks, and Contingencies
Future Compliance Risks:
- Strict Enforcement: If the Company falls out of compliance with the Minimum Stockholders' Equity Rule again within the one-year monitoring period (through January 7, 2027), it will not be permitted to submit a plan of compliance or receive additional cure time.
- Delisting Consequence: A recurrence of non-compliance will result in an immediate Delist Determination Letter. The Company would then have the opportunity to request a hearing, but its securities may be delisted from Nasdaq.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance to ensure it remains above the $2.5 million threshold.
- Monitor upcoming financial reports for any indicators of equity erosion that could trigger the strict delisting provisions.
- Confirm the exact end date of the mandatory panel monitor (January 7, 2027).
- Review the Company's capitalization strategy to understand how it intends to maintain equity levels over the next 12 months.